Moderate Sedation and Patient Monitoring
Sedation is a continuum
Moderate sedation is a drug-induced depression of consciousness during which the patient responds purposefully to verbal commands or light tactile stimulation, maintains a patent airway, and has adequate spontaneous ventilation. The same drugs can produce deep sedation or general anesthesia, so the provider must be prepared to rescue one level deeper. Pre-sedation assessment includes ASA class, airway examination (Mallampati, neck mobility, dentition), fasting status (2 hours clear liquids, 6 hours light meal, 8 hours fatty meal), and a monitoring plan.
Standard monitoring is pulse oximetry, noninvasive blood pressure, ECG for at-risk patients, and continuous observation of ventilation. Capnography detects hypoventilation and apnea earlier than pulse oximetry and is recommended for deep sedation and increasingly for moderate sedation. Supplemental oxygen treats hypoxemia but can mask hypoventilation; verify chest rise and capnography, not just the saturation.
Midazolam and fentanyl are synergistic: give small incremental doses and allow 3-5 minutes between doses. Flumazenil (0.2 mg IV, repeated as needed) reverses benzodiazepines but can precipitate seizures in chronic users and has a shorter half-life than midazolam, so observe for resedation. Naloxone reverses opioids similarly. Propofol has no reversal agent and requires airway skills.
Discharge criteria include stable vital signs, return of baseline consciousness and ambulation, and control of pain and nausea; use a validated scale such as Aldrete and document a responsible escort.
Worked example: a patient becomes hypoxemic at SpO2 85% after midazolam and fentanyl. Stop the procedure, call for help, perform jaw thrust, suction, and give oxygen. If ventilation does not improve, give flumazenil and naloxone and be ready to bag-mask ventilate. The common trap is escalating oxygen without addressing airway obstruction.